[resources] Bentham Science pharmaceutical journal full text database is open for trial notice.

Release time: 2018-09-28

article provenance: Ministry of resources construction

article author: Zhang Qian

Platform introduction

Bentham Science, as one of the international STM publishers, publishes more than 120 journals, 600 e-books and more than 60 peer-reviewed OA journals. Bentham Science is the only patent journal in the world. Many of Bentham Science's well-known journal editors are key opinion leaders in their field. All journals are included by authoritative digest/index agencies, such as SCOPUS, Thomson Reuters, PubMed, Medline, CA, Reaxys, EI, JSTOR, INSPEC, EMBASE, BIOSIS Previews, CSA/ProQuest, etc., which can help contributors to fully implement their research. Ability. Bentham Science publishes high-quality publications with the support and recommendation of many Nobel Prize winners and distinguished scientists, and strives to provide users with generous discounts, convenient access patterns, global users including many international academic alliances and well-known pharmaceutical companies.

The discipline of Bentham Science publications is as follows:

Pharmaceutical: Pharmaceutical Chemistry, Pharmaceutical Analysis, Pharmacology, Pharmaceutical Science, Natural Pharmaceutical Chemistry, Drug Metabolism, Clinical Pharmacy, Toxicology, Drug Treatment, Medicinal Organic Chemistry, Inorganic Chemistry and Analytical Chemistry, Combinatorial Chemistry, Chemical Biology, Biological Activity and Gene Therapy, Clinical Rational Drug Use, Photochromic Spectrum Research, drug targeting and screening, drug safety and the development, design and synthesis of various drugs.

Medical: Molecular medicine, immunology, biochemistry, biotechnology, biological information, drug therapy for systemic diseases such as cardiovascular system, respiratory system, endocrine system, tumor system, infectious disease, geriatric disease, allergy, stem cell therapy

Patents: drug research and development, design, inventions, formulations, biomarkers, bioengineering, and gene sequences.

Usage method

The IP address is authorized and can be accessed directly within the authorized address. Click to enter.

Trial deadline: December 25, 2019

If you have any problems during the probation period, please contact the Ministry of resources and construction: 84396021.

Explanation: this database is a trial database and will be closed during the probation period. Whether or not to purchase will be decided by various practical factors, such as funds, please understand.